C

Catalyst Pharmaceuticals
D

CPRX

21.375
USD
0.11
(0.49%)
مفتوح الان
حجم التداول
7,248
الربح لكل سهم
2
العائد الربحي
-
P/E
18
حجم السوق
2,548,873,327
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    ANIP
    0.100
    (0.19%)
    53.520 USD
    A
    ARWR
    0.150
    (0.77%)
    19.600 USD
    E
    ERYP
    -0.02670
    (-3.45%)
    0.70000 USD
    I
    INO
    -0.03000
    (-1.64%)
    1.80000 USD
    K
    KPTI
    -0.00030
    (-0.05%)
    0.64400 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    R
    RARE
    -1.050
    (-2.38%)
    43.140 USD
    المزيد
الأخبار
المقالات

العنوان: Catalyst Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.